Although the mechanisms need further examination, it is assumed that during obesity-related inflammation, increased concentrations of various proinflammatory cytokines inhibit adiponectin transcription, but this could also be related to dyslipidemia, which negatively correlates with adiponectin levels [80,81]. Here, ADIPOQ is linked to obesity disorder.